Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden.

Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

The month of September was a big one for mergers and acquisitions (M&As) in the biotech industry. There were four billion-dollar acquisitions that were the most notable. The top buyout was Danish ...

First, let’s take a look at the private biotech investments in September 2025, breaking them down by value, location, funding type, and therapeutic subsector. We can see from the table below that, in ...